Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Skarke

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Circulation. Genomic and Precision Medicine|August 20, 2020
Diet-Epigenome AxisCarsten Skarke
Science Translational Medicine|April 9, 2010
Training translators for smart drug discoveryCarsten Skarke, Garret A FitzGerald
Clinical Therapeutics|December 3, 2014
Selective COX-2 inhibitors suppress prostacyclinCarsten Skarke, Garret A FitzGerald
Genomics|October 16, 2003
Simultaneous screening for three mutations in the ABCB1 geneJörn Lötsch, Carsten Skarke, Gerd Geisslinger
Pain|June 29, 2005
Is morphine-3-glucuronide of therapeutic relevance?Carsten Skarke, Gerd Geisslinger, Jörn Lötsch
Clinical Pharmacokinetics|November 9, 2004
Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectivesJörn Lötsch, Carsten Skarke, Jürgen Liefhold, et al.
Clinical Chemistry|February 26, 2004
Comprehensive mu-opioid-receptor genotyping by pyrosequencingCarsten Skarke, Anja Kirchhof, Gerd Geisslinger, et al.
European Journal of Clinical Pharmacology|November 25, 2005
Rapid genotyping for relevant CYP1A2 alleles by pyrosequencingCarsten Skarke, Anja Kirchhof, Gerd Geisslinger, et al.
Clinical Pharmacokinetics|February 5, 2002
Drug interactions with patient-controlled analgesiaJorn Lotsch, Carsten Skarke, Irmgard Tegeder, et al.
Clinical Pharmacology and Therapeutics|September 13, 2005
The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depressionJörn Lötsch, Carsten Skarke, Andreas Schneider, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Circulation. Genomic and Precision Medicine|August 20, 2020
Diet-Epigenome AxisCarsten Skarke
Science Translational Medicine|April 9, 2010
Training translators for smart drug discoveryCarsten Skarke, Garret A FitzGerald
Clinical Therapeutics|December 3, 2014
Selective COX-2 inhibitors suppress prostacyclinCarsten Skarke, Garret A FitzGerald
Genomics|October 16, 2003
Simultaneous screening for three mutations in the ABCB1 geneJörn Lötsch, Carsten Skarke, Gerd Geisslinger
Pain|June 29, 2005
Is morphine-3-glucuronide of therapeutic relevance?Carsten Skarke, Gerd Geisslinger, Jörn Lötsch
Clinical Pharmacokinetics|November 9, 2004
Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectivesJörn Lötsch, Carsten Skarke, Jürgen Liefhold, et al.
Clinical Chemistry|February 26, 2004
Comprehensive mu-opioid-receptor genotyping by pyrosequencingCarsten Skarke, Anja Kirchhof, Gerd Geisslinger, et al.
European Journal of Clinical Pharmacology|November 25, 2005
Rapid genotyping for relevant CYP1A2 alleles by pyrosequencingCarsten Skarke, Anja Kirchhof, Gerd Geisslinger, et al.
Clinical Pharmacokinetics|February 5, 2002
Drug interactions with patient-controlled analgesiaJorn Lotsch, Carsten Skarke, Irmgard Tegeder, et al.
Clinical Pharmacology and Therapeutics|September 13, 2005
The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depressionJörn Lötsch, Carsten Skarke, Andreas Schneider, et al.
Pageof 7